AI Longevity Opportunities

Research and industry signals worth investigating.

About 5 min Past editions
More sections

Signals First (Citable Judgments)

  • Fight Aging! newsletter keeps thousands of subscribers hooked, and its founder Reason runs a longevity industry consulting gig — so yeah, there’s a real audience for longevity content and demand for industry advisory work. But this week’s batch doesn’t pack any specific research breakthroughs, so don’t mistake it for a “fresh discovery today” signal. Source: https://www.fightaging.org/archives/2026/11/fight-aging-newsletter-november-2nd-2026/ , Type: industry media weekly, Stage: published routine content distribution. The following judgment is an editorial opportunity inference, not a verified revenue claim.

  • RETFound — a retinal ViT foundation model getting repurposed for cardiovascular risk screening and retinal biological age estimation — popped up as a GitHub project on Trending, which tells us developers are sniffing around the “retinal imaging → systemic health metrics” direction. But hold your horses: the project has a grand total of 1 star, and the README, license, and data entry all need a proper look. Don’t treat it as a sign of technical maturity or commercial readiness. Source: https://github.com/agnikitha/retfound-cvd-screening , Type: GitHub project, Stage: very early-stage personal project, functionality unverified.

Today’s Top Pick

Content Topic & Project Monitoring for Retinal Imaging + AI Foundation Model Research

RETFound and similar retinal imaging foundation models are being explored for cardiovascular risk and biological age estimation — it’s an AI-meets-longevity crossover that clearly sparks reader interest but is nowhere near mature. Today you can cheaply put together a research direction observation piece + a project tracking table. What you should not do is frame it as a validated diagnostic tool.

  • Evidence sources: Fight Aging! Newsletter, November 2nd 2026 ( https://www.fightaging.org/archives/2026/11/fight-aging-newsletter-november-2nd-2026/ , industry media weekly, published); agnikitha/retfound-cvd-screening ( https://github.com/agnikitha/retfound-cvd-screening , GitHub project, very early stage, functionality pending review)
  • Credibility: Low (project has 1 star, README/license/data unverified; Fight Aging! this issue carries no specific research content)
  • Target pond: Content readers curious about the AI-longevity crossover, plus wearable/health hardware fans who want to geek out on cutting-edge methods
  • Pain point & payment rationale: Hypothesis — these readers want a fast read on frontier questions like “can retinal imaging infer whole-body health” but lack the time to chase down original papers and GitHub repos; willingness to pay is still unverified
  • Deliverable: A short research direction observation article + an AI retinal health research project tracking table (project name, star count, status, model, dataset, license)
  • Best fit for: Content topic
  • Minimum cost validation: Today, write a short Xiaohongshu/WeChat Official Account post. Title direction: “AI reads cardiovascular from retinal images: what a 1-star GitHub project tells us.” Slap on the project link, then watch reads/saves/DMs
  • Success metric: If within 7 days the post pulls 30+ saves or 3+ legit DMs asking “where can I find more projects like this,” it’s worth pushing forward with the tracking table
  • Stop condition: If within 7 days reads sit below your daily average and no DMs come in, the direction doesn’t have enough reader interest — drop the tracking table idea
  • Repurchase or upgrade path: The tracking table can grow into a paid resource pack — “AI Longevity Research Direction Navigator”; later you could do weekly project monitoring
  • After-sales or compliance risk: Medium
  • Compliance boundary: Do not claim retinal imaging can diagnose cardiovascular disease or measure biological age. Frame it strictly as research direction observation and project tracking, slap a “not clinically validated” label on it, and never suggest readers use any tool for personal health decisions
  • Today’s minimum action: Write a 200–300 word Xiaohongshu short post introducing the RETFound direction + this GitHub project, clearly tagged “very early-stage personal project, functionality unverified, for research interest tracking only”

Testable Small Opportunities

  • Longevity content reader community traffic test: Publish a Chinese longevity news summary post on the same day the Fight Aging! weekly drops. Title something like “One GitHub project worth watching in the longevity space this first week of November.” Drop a WeChat group entry at the end. Watch how many people join over 7 days. Target pond: Chinese longevity/anti-aging content readers. Deliverable: short post + group QR code. Don’t go all in yet — there’s zero evidence of Chinese reader demand, this is just an interest signal test.

  • AI health research project tracking table prototype: Spin up a 5-row table in Notion or Feishu with columns for project name/URL/star count/model/dataset/license/status/notes. Fill in retfound-cvd-screening as row one. Post it to your Moments or a community group and see if anyone bites with “got more of these?” Target pond: the overlap of AI developers and longevity content readers. Don’t go all in — one project can’t tell you if demand is real. If nobody asks, park it at 1 row and move on.

Project & Tool Leads

  • agnikitha/retfound-cvd-screening ( https://github.com/agnikitha/retfound-cvd-screening ): Python project that takes a swing at using RETFound ViT-Large for cardiovascular risk screening (CIMT), retinal biological age, and 5-disease screening. 1 star, README and license pending review. Could become the first entry in your tracking table and double as content topic material. Don’t try running it today though — the dataset and install flow are unverified, and since it touches health judgment functionality, compliance risk runs hot.

Don’t Touch Today

  • Don’t repackage this GitHub project as a ready-to-use personal health judgment tool for promotion or secondary development. The project sits at 1 star, functionality is unverified, it’s an unvalidated personal health judgment tool, compliance risk is high, and the after-sales headache would be brutal.

  • Don’t dress up this Fight Aging! weekly issue as material with specific research breakthroughs. The content is a routine weekly roundup and subscription info — no citable new research conclusions in there. Forcing a hot take would basically be making stuff up.

Today’s Actions

  • What to write today: A short Xiaohongshu/WeChat Official Account post introducing the RETFound retinal direction + the 1-star GitHub project, positioned as research interest tracking
  • What to test today: After the post goes live, watch 7-day saves and DM count to gauge Chinese reader interest in this direction
  • What to organize today: A 5-row Notion/Feishu AI health research project tracking table — fill in 1 entry to start
  • How to validate today: 30+ saves or 3 legit DMs = green light to continue; anything below = stop
  • What to avoid today: Don’t cook up any personal health judgment tool concepts based on this project’s functionality; don’t package the Fight Aging! routine weekly as a research breakthrough
11-01-Daily